| Active ingredient (INN) | Fosaprepitant |
|---|---|
| Therapeutic category | Auto-created by FDA Drug Enforcement — Full Recall Database scraper |
| Controlled substance | No |
|---|
| Marketing-authorisation holders | Juno Pharmaceuticals Pty Ltd, Medicianz Healthcare Pty Ltd, AFT Pharmaceuticals Pty Ltd, HIKMA PHARMACEUTICALS USA INC. +5 more |
|---|
| Registrations on file | 11 |
|---|
| Patient information leaflet (PIL) | Not on file |
|---|
| Summary of product characteristics (SPC) | Not on file |
|---|
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| Msn | 150 mg | — | 🇦🇺 AU | — | Active |
| Juno | 150 mg | — | 🇦🇺 AU | Juno Pharmaceuticals Pty Ltd | Active |
| Medicianz | 150 mg | — | 🇦🇺 AU | Medicianz Healthcare Pty Ltd | Active |
| Medsurge | 150 mg | — | 🇦🇺 AU | Medicianz Healthcare Pty Ltd | Active |
| Aft | 150 mg | — | 🇦🇺 AU | AFT Pharmaceuticals Pty Ltd | Active |
| Fosaprepitant Dimeglumine | 150mg/5mL | injection | 🇺🇸 US | HIKMA PHARMACEUTICALS USA INC. | Active |
| EMEND IV fosaprepitant | 150mg | — | 🇦🇺 AU | Merck Sharp & Dohme Australia Pty Ltd | Active |
| Fosaprepitant | 150mg/5mL | injection | 🇺🇸 US | BAXTER HEALTHCARE CORPORATION | Active |
| Fosaprepitant | 150mg/1 | injection | 🇺🇸 US | ACTAVIS PHARMA, INC. | Active |
| Fosaprepitant For | — | solution | 🇨🇦 CA | JUNO PHARMACEUTICALS CORP. | Active |
| FOSAPREPITANT | — | solution | 🇨🇦 CA | APOTEX INC | Active |